血管壁强化预测烟雾病动脉狭窄进展及不良结局
本研究前瞻性纳入170例烟雾病患者,基线和随访时行高分辨率磁共振血管壁成像,发现基线血管壁强化与动脉狭窄快速进展(aOR=3.57)及未来卒中发生(aHR=3.59)独立相关,提示血管壁强化可作为疾病进展和不良结局的预测指标。
要点
- 基线HRMR显示血管壁强化提示动脉狭窄快速进展风险增高。
- 血管壁强化和狭窄快速进展均与未来卒中风险独立相关。
- 报告烟雾病HRMR时需描述血管壁强化及其进展。
核心结论
- 基线血管壁强化与烟雾病患者动脉狭窄快速进展及未来卒中风险增加独立相关,可作为疾病进展和不良结局的预测指标。
研究设计与样本
- 前瞻性队列研究,连续纳入170例烟雾病患者(平均年龄37.7±11.3岁,男性44.1%),基线及随访时行HRMR血管壁成像,随访间隔≥6个月,临床随访≤24个月记录缺血性卒中发生。
关键影像表现/征象
- HRMR血管壁成像共识别309个颈内动脉狭窄病变。
- 基线血管壁强化、血管壁强化进展及大脑中动脉受累与动脉狭窄快速进展显著相关。
诊断标准与关键数值
- 基线血管壁强化与动脉狭窄快速进展的aOR=3.57(95%CI 1.97-6.44,p<0.001)。
- 血管壁强化进展与动脉狭窄快速进展的aOR=2.96(95%CI 1.29-6.80,p=0.010)。
- 大脑中动脉受累与动脉狭窄快速进展的aOR=4.98(95%CI 1.50-16.52,p=0.009)。
- 血管壁强化与未来卒中发生的aHR=3.59(95%CI 1.33-9.70,p=0.011)。
- 动脉狭窄快速进展与未来卒中发生的aHR=4.52(95%CI 1.48-13.81,p=0.008)。
临床应用与阅片要点
- 在烟雾病HRMR血管壁成像报告中,应描述血管壁强化的存在及其随访变化。
- 基线存在血管壁强化提示需密切影像随访以监测动脉狭窄快速进展。
- 血管壁强化和狭窄快速进展可辅助识别未来卒中高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to determine the association between vessel wall enhancement and progression of arterial stenosis and clinical outcomes in patients with moyamoya (MMD) using high-resolution magnetic resonance (HRMR) vessel wall imaging.
METHODS: Consecutive participants diagnosed with MMD were prospectively recruited and underwent HRMR at baseline and during follow-up, which had an interval period of ≥ 6 months and were clinically followed up for ≤ 24 months to record the occurrence of ischemic stroke. The relationship between vessel wall enhancement and arterial stenosis progression and stroke occurrence was evaluated.
RESULTS: HRMR vessel wall imaging was used to identify 309 stenotic lesions at the internal carotid artery (ICA) in 170 participants (mean age: 37.7 ± 11.3 years old, male: 44.1%). The baseline presence (adjusted odds ratio [aOR] = 3.57, 95% CI = 1.97-6.44, p < 0.001) and progression (aOR = 2.96, 95% CI = 1.29-6.80, p = 0.010) of vessel wall enhancement and middle cerebral artery (MCA) involvement (aOR = 4.98, 95% CI = 1.50-16.52, p = 0.009) were significantly associated with rapid progression of arterial stenosis. Furthermore, vessel wall enhancement (adjusted HR = 3.59, 95% CI = 1.33-9.70, p = 0.011) and rapid progression of arterial stenosis (adjusted HR = 4.52, 95% CI = 1.48-13.81, p = 0.008) were correlated with future stroke occurrence.
CONCLUSION: The baseline presence of vessel wall enhancement was associated with rapid progression of arterial stenosis and increased risk for stroke in MMD patients. Our findings suggest that vessel wall enhancement may serve as a predictor of disease progression and poor outcomes in MMD.
KEY POINTS: • The baseline presence of vessel wall enhancement was significantly associated with the rapid progression of arterial stenosis. • The baseline presence of vessel wall enhancement and rapid progression of arterial stenosis were both correlated with increased risk for future occurrence of stroke. • Our findings suggest that vessel wall enhancement may serve as a predictor of rapid progression of arterial stenosis and poor outcomes in MMD patients.
引用
- Lu, Zhang, Liu, et al. Vessel wall enhancement as a predictor of arterial stenosis progression and poor outcomes in moyamoya disease. Eur Radiol. 2022. PMID: 36334103. doi:10.1007/s00330-022-09223-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。